Multifunctional Liposomes For Imaging-Guided Therapy
Xiuli Yue,Zhifei Dai
DOI: https://doi.org/10.1007/978-3-662-48544-6_10
2016-01-01
Abstract:Liposomes has enjoyed an explosive development in nanomedicine due to the exciting feature of easy combinations of diagnostic and/or therapeutic agents into a single agent. A variety of multifunctional liposomes have been developed by loading various therapeutic agents (e.g., radionuclides, doxorubicin, paclitaxel, siRNA, DNA) and imaging contrast agents (e.g., radionuclides, quantum dots, Gd complex, and Fe3O4). Each component would operate a different function, such as molecular targeting, contrast-enhanced imaging (e.g., nuclear, fluorescence, magnetic resonance, CT, photoacoustic, and ultrasound), and therapy (e.g., chemotherapy, photothermal therapy, photodynamic therapy, gene therapy, or combined therapy). Moreover, the surface of liposomes can be easily modified with ligands for targeting delivery to the diseased sites. In addition, the multimodality imaging functionalization of therapeutic drug carrying liposomes is of particular interest for personalized monitoring of the in vivo tumor targeting and pharmacokinetics of liposomal therapeutic agents, predicting therapy outcome, and gaining a better understanding of the prognosis-associated disease status by combining the advantageous information from each imaging modality. Therefore, multifunctional liposomes can serve as a theranostic nanomedicine for noninvasive imaging diagnosis, real-time imaging guidance, and remote-controlled therapeutics, especially imaging-guided therapeutics, enabling personalized detection and treatment of diseases with high efficacy. However, liposomes still have not attained their full potential because of insufficient stability. Recently, a hybrid liposomal cerasome with high stability has been developed to overcome general problems associated with current liposome technology. The present chapter first highlights some of the key advances of theranostic liposomes for imaging-guided therapy as a tool in personalized medicine.